G01N 2333/20
From spirochaetales
Official title: from Spirochaetales (O), e.g. Treponema, Leptospira
G01N2333/20 (From spirochaetales) appears on 147 US grants and 232 published applications in this corpus.
Search patents in G01N- Granted patents
- 147
- Published applications
- 232
- Assignees
- 121
- Inventors
- 354
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 0 |
| 2003 | 0 | 5 |
| 2004 | 4 | 2 |
| 2005 | 1 | 5 |
| 2006 | 2 | 12 |
| 2007 | 0 | 2 |
| 2008 | 2 | 3 |
| 2009 | 0 | 3 |
| 2010 | 5 | 8 |
| 2011 | 4 | 12 |
| 2012 | 8 | 8 |
| 2013 | 4 | 14 |
| 2014 | 11 | 11 |
| 2015 | 13 | 17 |
| 2016 | 10 | 13 |
| 2017 | 8 | 12 |
| 2018 | 9 | 13 |
| 2019 | 12 | 11 |
| 2020 | 11 | 9 |
| 2021 | 7 | 13 |
| 2022 | 5 | 16 |
| 2023 | 8 | 8 |
| 2024 | 5 | 15 |
| 2025 | 8 | 8 |
| 2026 | 5 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multi-antigen diagnostic for detecting lyme disease26 May 2026US 12,638,446 B2Focus on Lyme Foundation
- Species-specific antigen sequences for tick-borne relapsing fever (TBRF) and methods of use19 May 2026US 12,631,635 B2ID-Fish Technology, Inc.
- Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes31 Mar 2026US 12,590,960 B2Ortho-Clinical Diagnostics, Inc.
- Methods of diagnosing or treating Lyme disease3 Mar 2026US 12,566,180 B2Drexel University
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies27 Jan 2026US 12,535,481 B2Virginia Tech Intellectual Properties, Inc.
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Methods of diagnosing or treating lyme disease20 Aug 2026US 2026/0243778 A1Drexel University
- Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes16 Jul 2026US 2026/0202405 A1Ortho-Clinical Diagnostics, Inc.
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Affinity Matrix Compositions and Methods of Use Thereof18 Jun 2026US 2026/0166521 A1George Mason University
Most cited
By later US patents
- Modified cardiolipin and uses therefor34US 8,906,603 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2014
- VMP-like sequences of pathogenic Borrelia29US 6,719,983 B2Board of Regents, The University of Texas System · 2004
- Neutralization of polycations in a chromatographic device for whole blood use27US 6,673,629 B2Abbott Laboratories · 2004
- VMP-like sequences of pathogenic Borrelia25US 7,135,176 B2Board of Regents, The University of Texas System · 2006
- VMP-like sequences of pathogenic borrelia22US 6,437,116 B1Board of Regents, The University of Texas System · 2002